loader2
NRI

Nov 19, 2024


Category

Equity

AUM (Cr.)

1,382.60

Exit Load (%)

1.00

Min Inv Lumpsum

100

Expense Ratio

2.18

Sharpe Ratio

33.07

Beta Ratio

0.00

Fund Manager

Nikhil Mathur

Inception Date

Oct 04, 2023

Risk Level

Very High

Investment Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related s securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - HDFC Pharma and Healthcare Fund - Regular (G) -2.29 25.39 50.99 0 0 50.8
Benchmark - S&P BSE Healthcare TRI -1.88 10.85 37 11.94 22.91 0
Category Average - BEST EQUITY PERFORMERS -5.9 6.66 30.15 16.56 21.21 16.27
Category Rank 7/7 7/7 6/7 7/7 7/7 7/7
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India Taiwan Equity Fund (IDCW) 11.4604 2.98 25.58 0.00 0.00 364.14 2.43 500.00 invest
Nippon India Taiwan Equity Fund (G) 11.4604 2.98 25.58 0.00 0.00 364.14 2.43 500.00 invest
SBI Automotive Opportunities Fund - Regular (G) 9.6655 1.62 0.00 0.00 0.00 6,003.23 1.79 5,000.00 invest
SBI Automotive Opportunities Fund - Regular (IDCW) 9.6656 1.62 0.00 0.00 0.00 6,003.23 1.79 5,000.00 invest
SBI Energy Opportunities Fund - Regular (G) 10.1076 -0.49 0.00 0.00 0.00 10,889.77 1.72 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Oct 31, 2024 193.79 14.02 28.64
Equity-Cipla Oct 31, 2024 112.91 8.17 58.15
Equity-Divi`s Lab. Oct 31, 2024 109.31 7.91 14.20
Equity-Lupin Oct 31, 2024 86.44 6.25 24.63
Equity-Ipca Labs. Oct 31, 2024 56.35 4.08 6.05
Equity-Gland Pharma Oct 31, 2024 55.35 4.00 29.03
Equity-Aurobindo Pharma Oct 31, 2024 47.58 3.44 -4.39
Equity-Piramal Pharma Oct 31, 2024 47.11 3.41 17.23
Equity-Dr Reddy`s Labs Oct 31, 2024 45.87 3.32 -5.64
Equity-ERIS Lifescience Oct 31, 2024 45.28 3.27 9.17

latest news

HDFC MF announces Income Distribution cum capital withdrawal (IDCW) under its scheme

HDFC Mutual Fund has announced 25 November 2024 as the record date for decl...

Nov 21, 2024 09:41

HDFC MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme

HDFC Mutual Fund has announced 21 November 2024 as the record date for decl...

Nov 18, 2024 10:31

HDFC MF announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes

HDFC Mutual Fund has announced 21 November 2024 as the record date for decl...

Nov 18, 2024 09:37

HDFC Mutual Fund announces change in scheme name

HDFC Mutual Fund has announced change in scheme name under the following sc...

Nov 05, 2024 10:57

HDFC MF announces Income Distribution cum capital withdrawal (IDCW) under its scheme

HDFC Mutual Fund has announced 25 October 2024 as the record date for decla...

Oct 23, 2024 16:25

HDFC MF announces Income Distribution cum Capital Withdrawal (IDCW) under two schemes

HDFC Mutual Fund has announced 24 October 2024 as the record date for decla...

Oct 22, 2024 09:41

SCHEME DETAILS

AMC Name : HDFC Mutual Fund
Fund Name : HDFC Pharma and Healthcare Fund - Regular (G)
Contact Persone : Nikhil Mathur
Registered Address : HDFC House, 2nd Flr, H.T.Parekh Marg,165-166, Backbay Reclamation,Churchgate, Mumbai - 400 020.
Telephone No : 022 - 6631 6333
Fax No. : 022 - 22821144
Email : hello@hdfcfund.com
Website : www.hdfcfund.com